Zimmer Biomet Holdings, Inc. (zbh)

ZBH — Company Overview

Investors tracking ZBH follow a Medical Devices name listed on NYQ within Healthcare.

ZBH — Business Description

The business profile of Zimmer Biomet Holdings, Inc. (ZBH) reflects its role in Medical Devices. Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It…

Official website: https://www.zimmerbiomet.com.

ZBH — Investment Thesis

Zimmer Biomet Holdings, Inc. (ZBH) attracts investors weighing Medical Devices fundamentals against current market pricing.

• Revenue is expanding at roughly 4.8% year-over-year (public data).
• Trailing P/E of 22.06× sits in a moderate band relative to high-growth peers.
• Forward P/E (10.02×) is below trailing P/E — earnings may be expected to improve.
• Dividend yield near 1.0% adds an income component to total return.
• Equity market capitalization is approximately $17.33B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

ZBH — Financial Health

ZBH financial profile reflects operating efficiency and capital structure using available market fundamentals.

Profit margin near 9.5% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $1.07B supports balance-sheet flexibility.

ZBH — Growth Outlook

Growth outlook for Zimmer Biomet Holdings, Inc. (ZBH) depends on demand trends in Medical Devices and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 4.8% suggests steady but measured expansion.
• Earnings growth of 33.8% year-over-year supports improving profitability.
• Price is 15.0% below the 52-week high.
• Shares trade 14.9% above the 52-week low — limited rebound so far.

ZBH — Competitive Position

Zimmer Biomet Holdings, Inc. (ZBH) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Medical Devices.
• Market capitalization of $17.33B places ZBH among large-cap peers.
• Gross margin near 69.5% may reflect pricing power or favorable mix.

ZBH — Summary

Zimmer Biomet Holdings, Inc. (ZBH) is a large-cap Healthcare company focused on Medical Devices, listed on NYQ. Last price $90.88 with market cap $17.33B. Trailing P/E 22.06×. Revenue grew 4.8% year-over-year per public data. Notable strengths include earnings growth of 33.8% year-over-year. Review free estimates and earnings pages for ZBH; upgrade for institutional ownership and live headlines.